可切除的胰腺导管腺癌的临床试验
总计2843个结果
-
University Hospital, MontpellierAIDS Malignancy Consortium主动,不招人
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的Histologically or Cytologically Confirmed Pancreatic Ca | Unresectable or Borderline Resectable Pancreatic Ca美国
-
Genentech, Inc.BioNTech SE招聘中
-
Amal TherapeuticsBoehringer Ingelheim招聘中
-
University Hospital, GrenobleNETRIS Pharma招聘中
-
University Health Network, Toronto招聘中
-
Washington University School of MedicineBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of Health (NIH); The...主动,不招人
-
Invitae CorporationEastern Cooperative Oncology Group终止
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)终止胰腺肿瘤 | 胰腺癌 | 转移性胰腺癌 | 经组织学或细胞学证实的胰腺癌 | 不可切除或临界可切除胰腺癌美国
-
Revolution Medicines, Inc.招聘中
-
Azienda Ospedaliera Universitaria Integrata Verona招聘中
-
Tianjin Medical University Cancer Institute and...尚未招聘PDAC-- 胰腺导管腺癌
-
Belgian Group of Digestive OncologyUniversity Hospital St Luc, Brussels招聘中
-
British Columbia Cancer AgencyCanadian Cancer Society (CCS); SignalChem Lifesciences Corporation终止
-
University Hospital, AntwerpUniversitair Ziekenhuis Brussel; General Hospital Groeninge; AZ Nikolaas; Erasme University Hospital 和其他合作者主动,不招人
-
Ambry GeneticsBeth Israel Deaconess Medical Center; HonorHealth Research Institute; University of Pittsburgh...完全的
-
The Rogosin InstituteVital Systems Inc.完全的
-
Georgetown UniversityMerck Sharp & Dohme LLC; BioXcel Therapeutics Inc招聘中
-
Novartis Pharmaceuticals主动,不招人转移性胰腺导管腺癌美国, 中国, 匈牙利, 台湾, 比利时, 德国, 西班牙, 意大利, 捷克语, 法国, 日本, 瑞士, 澳大利亚, 以色列, 大韩民国, 加拿大, 俄罗斯联邦, 斯洛伐克, 英国, 火鸡, 瑞典, 希腊, 芬兰, 荷兰, 挪威, 巴西, 新加坡
-
Washington University School of MedicineNational Cancer Institute (NCI)招聘中